In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eliance Biotechnology Inc.

Division of MacroGenics Inc.
www.elibio.com

Latest From Eliance Biotechnology Inc.

MacroGenics and Eliance: Acknowledging Weakness Led to Counting Blessings

An increasingly popular recipe for reducing risk calls for merging young companies. The recent acquisition by MacroGenics of Eliance Biotechnology reduces both management and financial risk, while creating a more integrated technology platform with broader potential than either company's alone.
BioPharmaceutical

Selected Start-Ups (03/01)

In Vivo summarizes the technology of several recently founded companies: Germany's Curacyte AG was formed to commercialize platforms in oncology, immunology and hematological disorders; Eliance Biotechnology Inc. has licensed a vaccine discovery platform that identifies the optimal antigens for vaccine production; Immerge Biotherapeutics will focus on the development of swine-based cells, tissues and organs for transplantation into humans; MedLynx Corp. aims to reduce hospital operating costs and reduce medical errors with its wireless, handheld medical information management system; Perlegen Sciences Inc. will read genomes from 50 individuals to discover and analyze patterns of genetic variation; Protiva Biotherapeutic Inc's gene delivery technology protects plasmid DNA from degradation as the particles are delivered through the bloodstream to their destination
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MacroGenics Inc.
  • Senior Management
  • Tom Turpen, Pres. & CSO
  • Contact Info
  • Eliance Biotechnology Inc.
    Phone: (214) 634-3000
    2600 Stemmons Freeway
    Suite 125
    Dallas, TX 75207
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register